NovelMed Therapeutics novelmed.com


Public list: Pharma Startups (6570) Eye Health (703)

NovelMed Therapeutics is a privately-held biotech company developing transformative treatments for orphan and non-orphan disease conditions. The company has developed a portfolio of antibodies targeted for the treatments of complement-mediated inflammatory and hemolytic disorders including paroxysmal nocturnal Hemoglobinuria (PNH), atypical hemolytic uremic syndrome (aHUS), age-related macular degeneration (Dry & Wet AMD), arthritis (RA & OA), and cardiovascular diseases. NovelMed's drug candida...Show all

NovelMed Therapeutics is a privately-held biotech company developing transformative treatments for orphan and non-orphan disease conditions. The company has developed a portfolio of antibodies targeted for the treatments of complement-mediated inflam...Show all

Company (Alive / Active)

All investors data 1 Investors

Phone: 216-707-1776

Fax:

BioEnterprise Building, 135
11000 Cedar Avenue
 Cleveland, 44106
 Ohio, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
NovelMed Therapeutics $1.4M Sep 12, 2013

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related NovelMed Therapeutics Jobs

jobs by Indeed job search

Investors

Investor Investor Type Location Participating Rounds
See all 1 investors
There is no Board of Directors data available for this company. Please select another tab.
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)
Aglycosylated human antibody and fusion protein and uses thereof Dec 28, 2012 Jul 14, 2020 Patent
Compositions and methods of treating ocular diseases Jan 22, 2019 Jun 30, 2020 Patent
Compositions and methods of treating ocular diseases Aug 06, 2014 Jan 22, 2019 Patent
Method of inhibiting complement activation with factor bb specific antibodies and use thereof Mar 16, 2015 Nov 20, 2018 Patent
Alternative pathway specific antibodies for treating hemolytic diseases Apr 06, 2015 Jun 05, 2018 Patent
See all 30 patents